Table 2. Drug concentration in plasma and brain 2 and 24 h after SC administration of an equivalent molar dose rate of MLs in Mdr1ab(−/−) mice.
Drug concentration in plasma (pmol/ml) | Drug concentration in brain (pmol/g) | Brain-to-plasma concentration ratio (ml/g) | ||||
2 h | 24 h | 2 h | 24 h | 2 h | 24 h | |
Ivermectin | 57.9±22.9 | 22.0±8.1 | 43.9±15.7 | 100.2±29.7 | 0.8±0.4 | 4.8±1.6 |
Moxidectin | 60.0±14.5 | 42.8±9.3*** | 18.8±2.8* | 93.0±28.9 | 0.3±0.1* | 2.2±0.7** |
Ivermectin (IVM) or moxidectin (MOX) was administered subcutaneously in Mdr1ab(−/−) mice (6 per drug) at similar molar dose rate (0.23 µmol/kg, corresponding to 0.20 mg/kg and 0.15 mg/kg for IVM and MOX, respectively). Mice were sacrificed at 2 or 24 h after treatment. Drug concentrations were determined in plasma and brain, and the brain/plasma concentration ratios were calculated.
p<0.05,
p<0.01,
p<0.001 vs IVM.